Literature DB >> 17764481

Determining the effective sample size of a parametric prior.

Satoshi Morita1, Peter F Thall, Peter Müller.   

Abstract

We present a definition for the effective sample size of a parametric prior distribution in a Bayesian model, and propose methods for computing the effective sample size in a variety of settings. Our approach first constructs a prior chosen to be vague in a suitable sense, and updates this prior to obtain a sequence of posteriors corresponding to each of a range of sample sizes. We then compute a distance between each posterior and the parametric prior, defined in terms of the curvature of the logarithm of each distribution, and the posterior minimizing the distance defines the effective sample size of the prior. For cases where the distance cannot be computed analytically, we provide a numerical approximation based on Monte Carlo simulation. We provide general guidelines for application, illustrate the method in several standard cases where the answer seems obvious, and then apply it to some nonstandard settings.

Mesh:

Year:  2007        PMID: 17764481      PMCID: PMC3081791          DOI: 10.1111/j.1541-0420.2007.00888.x

Source DB:  PubMed          Journal:  Biometrics        ISSN: 0006-341X            Impact factor:   2.571


  5 in total

1.  Quantifying and documenting prior beliefs in clinical trials.

Authors:  K Chaloner; F S Rhame
Journal:  Stat Med       Date:  2001-02-28       Impact factor: 2.373

2.  Dose-finding with two agents in Phase I oncology trials.

Authors:  Peter F Thall; Randall E Millikan; Peter Mueller; Sang-Joon Lee
Journal:  Biometrics       Date:  2003-09       Impact factor: 2.571

3.  Robust Bayesian methods for monitoring clinical trials.

Authors:  J B Greenhouse; L Wasserman
Journal:  Stat Med       Date:  1995-06-30       Impact factor: 2.373

4.  Partitioning degrees of freedom in hierarchical and other richly-parameterized models.

Authors:  Yue Cui; James S Hodges; Xiaoxiao Kong; Bradley P Carlin
Journal:  Technometrics       Date:  2010-02-01

Review 5.  Practical model-based dose-finding in phase I clinical trials: methods based on toxicity.

Authors:  P F Thall; S-J Lee
Journal:  Int J Gynecol Cancer       Date:  2003 May-Jun       Impact factor: 3.437

  5 in total
  45 in total

1.  Optimizing Sedative Dose in Preterm Infants Undergoing Treatment for Respiratory Distress Syndrome.

Authors:  Peter F Thall; Hoang Q Nguyen; Sarah Zohar; Pierre Maton
Journal:  J Am Stat Assoc       Date:  2014-09-01       Impact factor: 5.033

2.  Bayesian hierarchical classification and information sharing for clinical trials with subgroups and binary outcomes.

Authors:  Nan Chen; J Jack Lee
Journal:  Biom J       Date:  2018-12-03       Impact factor: 2.207

Review 3.  Contrast-associated acute kidney injury in the critically ill: systematic review and Bayesian meta-analysis.

Authors:  Stephan Ehrmann; Andrew Quartin; Brian P Hobbs; Vincent Robert-Edan; Cynthia Cely; Cynthia Bell; Genevieve Lyons; Tai Pham; Roland Schein; Yimin Geng; Karim Lakhal; Chaan S Ng
Journal:  Intensive Care Med       Date:  2017-02-14       Impact factor: 17.440

4.  Prior Effective Sample Size in Conditionally Independent Hierarchical Models.

Authors:  Satoshi Morita; Peter F Thall; Peter Müller
Journal:  Bayesian Anal       Date:  2012-09       Impact factor: 3.728

5.  Computing Expected Value of Partial Sample Information from Probabilistic Sensitivity Analysis Using Linear Regression Metamodeling.

Authors:  Hawre Jalal; Jeremy D Goldhaber-Fiebert; Karen M Kuntz
Journal:  Med Decis Making       Date:  2015-04-03       Impact factor: 2.583

6.  Simple Penalties on Maximum-Likelihood Estimates of Genetic Parameters to Reduce Sampling Variation.

Authors:  Karin Meyer
Journal:  Genetics       Date:  2016-06-17       Impact factor: 4.562

7.  Detecting and accounting for violations of the constancy assumption in non-inferiority clinical trials.

Authors:  Joseph S Koopmeiners; Brian P Hobbs
Journal:  Stat Methods Med Res       Date:  2016-09-01       Impact factor: 3.021

8.  Robust treatment comparison based on utilities of semi-competing risks in non-small-cell lung cancer.

Authors:  Thomas A Murray; Peter F Thall; Ying Yuan; Sarah McAvoy; Daniel R Gomez
Journal:  J Am Stat Assoc       Date:  2017-05-03       Impact factor: 5.033

9.  Bayesian hierarchical modeling based on multisource exchangeability.

Authors:  Alexander M Kaizer; Joseph S Koopmeiners; Brian P Hobbs
Journal:  Biostatistics       Date:  2018-04-01       Impact factor: 5.899

10.  Calculating the Expected Value of Sample Information in Practice: Considerations from 3 Case Studies.

Authors:  Anna Heath; Natalia Kunst; Christopher Jackson; Mark Strong; Fernando Alarid-Escudero; Jeremy D Goldhaber-Fiebert; Gianluca Baio; Nicolas A Menzies; Hawre Jalal
Journal:  Med Decis Making       Date:  2020-04-16       Impact factor: 2.583

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.